Medeon Biodesign (ROCO:6499) Operating Cash Flow per Share : NT$-6.26 (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Operating Cash Flow per Share?

Medeon Biodesign's operating cash flow per share for the three months ended in Mar. 2024 was NT$-1.90. Medeon Biodesign's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-6.26.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -23.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Medeon Biodesign's Operating Cash Flow per Share or its related term are showing as below:

ROCO:6499' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -45.9 Med: -1.1 Max: 25.3
Current: -23.8

During the past 12 years, Medeon Biodesign's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.30% per year. The lowest was -45.90% per year. And the median was -1.10% per year.

ROCO:6499's 3-Year OCF Growth Rate is ranked worse than
79.51% of 688 companies
in the Medical Devices & Instruments industry
Industry Median: 2.85 vs ROCO:6499: -23.80

Medeon Biodesign Operating Cash Flow per Share Historical Data

The historical data trend for Medeon Biodesign's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Operating Cash Flow per Share Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

4.03

-2.64

-1.65

-3.19

-5.01

Medeon Biodesign Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-1.41	-1.84	-2.31	-2.04	-1.90

Competitive Comparison of Medeon Biodesign's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medeon Biodesign's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Price-to-Operating-Cash-Flow falls into.

Medeon Biodesign Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Medeon Biodesign's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-461.34	/	92.017
	=	-5.01

Medeon Biodesign's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-175.277	/	92.117
	=	-1.90

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-6.26

Medeon Biodesign Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign (ROCO:6499) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines